Regulatory Updates: Page 36

FDA fast-tracks Galera's oral mucositis therapy
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration (FDA) has granted fast-track status to Galera Therapeutics for a drug that may reduce the severity and incidence of radiation- and chemotherapy-induced oral mucositis.
January 11, 2016
New dietary guidelines advise limiting intake of added sugars
By Theresa Pablos
The U.S. Department of Health and Human Services and the Department of Agriculture have released the "2015-2020 Dietary Guidelines for Americans," which includes a call to limit the intake of added sugars.
January 10, 2016
2014 09 19 14 47 01 805 Sugar Drinks 200
Kelsch, others reappointed to Calif. dental committees
By DrBicuspid.com staff writers
California Gov. Jerry Brown has reappointed four people, including DrBicuspid.com contributing writer Noel Kelsch, to the state's dental advisory committees and board.
January 7, 2016
FTC fines Henry Schein $250K over patient data encryption
By DrBicuspid.com staff writers
Henry Schein Practice Solutions will pay $250,000 to settle Federal Trade Commission (FTC) charges that the company falsely advertised the level of encryption it provided to protect patient data.
January 5, 2016
FDA OKs nonalcohol docetaxel for head/neck cancer
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration (FDA) has approved Teikoku Pharma USA's nonalcohol docetaxel injection for the treatment of head and neck cancer, breast cancer, non-small cell lung cancer, prostate cancer, and gastric adenocarcinoma.
December 28, 2015
Schein Financial offers PATH Act support
By DrBicuspid.com staff writers
Henry Schein Financial Services said it is ready to support practice owners interested in tax savings available through the recently enacted Protecting Americans From Tax Hikes (PATH) Act.
December 27, 2015
FDA fast-tracks Cellceutix's oral mucositis therapy
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration (FDA) has granted fast-track status to biopharmaceutical company Cellceutix for Brilacidin-OM, a mouth rinse to prevent oral mucositis.
November 24, 2015
FDA reclassifies salivary stimulator system
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration (FDA) issued a final order on November 20 to reclassify and rename what has been known as a salivary stimulator system.
November 19, 2015
Vigilant gets CE Mark for oral cancer test
By DrBicuspid.com staff writers
Vigilant Biosciences' OncAlert oral cancer CD44/total protein lab test has received the CE Mark, which allows the company to market the test in Europe.
November 15, 2015
U.S. federal court rules in favor of ClearCorrect over ITC
By Theresa Pablos
A U.S. federal court has ruled in favor of ClearCorrect in a case involving digital data, noting that the U.S. International Trade Commission does not have the authority to regulate the data. The case has implications that could affect how the Internet is regulated.
November 11, 2015
2013 11 18 17 15 05 637 Gavel 200
Collagen Matrix to participate in FDA learning program
By DrBicuspid.com staff writers
Collagen Matrix announced that the company has been selected to participate in the U.S. Food and Drug Administration (FDA) Experiential Learning Program.
November 11, 2015
ADA 2015: Solea gets FDA clearance for new procedures
By DrBicuspid.com staff writers
WASHINGTON, DC - Convergent Dental announced at the 2015 ADA meeting in Washington, DC, that its Solea dental laser has been cleared by the U.S. Food and Drug Administration (FDA) to perform osseous tissue procedures.
November 4, 2015
Previous Page
Page 36 of 78
Next Page